Precision Medicine
A Melbourne-based medical technology company has been granted a US$3 million contract to use digital health technology and AI to drive personalised medicine for the Epilepsy Foundation of America.
Translational research is a main focus point for the iTHRIV consortium, which brings together areas of expertise including genomics, clinical research, data science and more.
At the Food and Drug Administration, the physician and venture investor promoted policies focused on innovating approaches to population health, opioids, chronic disease, AI and precision medicine.
Australia’s Icon Group inks agreement with China’s Sanbo Brain Hospital Group to provide radiation …
Yesterday, Icon Group (Icon), Australia’s largest dedicated private provider of cancer care, officially signed an agreement with China’s Sanbo Brain Hospital Group (Sanbo) to deliver radiation oncology services, which are set to open later this year in their Chang’an hospital in Chongqing.
Murdoch University has opened the doors to a new research centre at its Perth campus, with a focus on precision medicine.
Health and research entities to advance genome sequencing for disease diagnosis.
Bumrungrad International partners with BC Platforms to offer personalised healthcare solutions for …
Last week, BC Platforms, an MIT Whitehead project spinoff which specialises in powerful genomic data management and analysis solutions, announced that it will be providing its genomics platform to Bumrungrad International Hospital, a private multiple-specialty medical centre founded 1980 in Bangkok, Thailand.
VivaLNK debuted an Internet of Things-enabled wearables sensor platform, TriFin Labs unveiled a patient engagement platform, eMDs launched a revenue cycle management system and Philips introduced an epidemiology system that uses genomics and deep learning.
Once the specification gains wider use for data exchange, it will open the doors for more advanced uses of data, including artificial intelligence and machine learning, IBM, Google and Microsoft executives said at HIMSS19.
They're big and expensive projects to get off the ground, and their ROI can't just be measured in dollars and cents, said an expert at HIMSS19: Value depends on the perspective of patients and physicians too.